ICD-10 Diagnosis Code C57.00

Malignant neoplasm of unspecified fallopian tube

Diagnosis Code C57.00

ICD-10: C57.00
Short Description: Malignant neoplasm of unspecified fallopian tube
Long Description: Malignant neoplasm of unspecified fallopian tube
This is the 2019 version of the ICD-10-CM diagnosis code C57.00

Valid for Submission
The code C57.00 is valid for submission for HIPAA-covered transactions.

Code Classification
  • Neoplasms (C00–D48)
    • Malignant neoplasms of female genital organs (C51-C58)
      • Malignant neoplasm of other and unsp female genital organs (C57)
Version 2019 Billable Code Diagnoses For Females Only

Information for Medical Professionals


Code Edits
The following edits are applicable to this code:
Diagnoses for females only - Diagnoses for females only.

Diagnostic Related Groups
The diagnosis code C57.00 is grouped in the following Diagnostic Related Group(s) (MS-DRG V35.0)

  • 736 - UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH MCC
  • 737 - UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITH CC
  • 738 - UTERINE AND ADNEXA PROCEDURES FOR OVARIAN OR ADNEXAL MALIGNANCY WITHOUT CC/MCC
  • 739 - UTERINE, ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH MCC
  • 740 - UTERINE, ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITH CC
  • 741 - UTERINE, ADNEXA PROCEDURES FOR NON-OVARIAN AND NON-ADNEXAL MALIGNANCY WITHOUT CC/MCC

Convert to ICD-9
  • 183.2 - Mal neo fallopian tube (Approximate Flag)

Synonyms
  • Any T/Any N and M1
  • Carcinoma of fallopian tube
  • Malignant tumor involving an organ by direct extension from fallopian tube
  • Malignant tumor involving an organ by separate metastasis from fallopian tube
  • Malignant tumor involving bladder by direct extension from fallopian tube
  • Malignant tumor involving bladder by separate metastasis from fallopian tube
  • Malignant tumor involving left ovary by direct extension from fallopian tube
  • Malignant tumor involving left ovary by separate metastasis from fallopian tube
  • Malignant tumor involving rectum by direct extension from fallopian tube
  • Malignant tumor involving rectum by separate metastasis from fallopian tube
  • Malignant tumor involving right ovary by separate metastasis from fallopian tube
  • Malignant tumor involving uterine cervix by direct extension from fallopian tube
  • Malignant tumor involving uterine cervix by separate metastasis from fallopian tube
  • Malignant tumor involving uterine corpus by direct extension from fallopian tube
  • Malignant tumor involving uterine corpus by separate metastasis from fallopian tube
  • Malignant tumor involving vagina by direct extension from fallopian tube
  • Malignant tumor involving vagina by separate metastasis from fallopian tube
  • Malignant tumor involving vulva by direct extension from fallopian tube
  • Malignant tumor involving vulva by separate metastasis from fallopian tube
  • Malignant tumor of fallopian tube
  • pM1
  • pN1
  • Primary adenocarcinoma of fallopian tube
  • Primary malignant neoplasm of fallopian tube
  • pT1
  • pT1a
  • pT1c
  • pT1c category
  • pT2
  • pT2a
  • pT2b
  • pT2c
  • pT2c category
  • pT3
  • pT3 and/or N1
  • pT3a
  • pT3b
  • pT3c
  • pT3c and/or N1
  • pT3c category
  • Secondary malignant neoplasm of body of uterus
  • Secondary malignant neoplasm of cervix uteri
  • Secondary malignant neoplasm of left ovary
  • Secondary malignant neoplasm of rectum
  • Secondary malignant neoplasm of right ovary
  • Secondary malignant neoplasm of vagina
  • Secondary malignant neoplasm of vulva
  • T1
  • T1a : Tumor limited to one fallopian tube without penetrating the serosal surface, no ascites
  • T1c with extension into or through the tubal serosa; or with malignant cells in ascites or peritoneal washings: FALLOPIAN TUBE: Salpingectomy
  • T2 with pelvic extension
  • T2a : Fallopian tube tumor with extension and/or metastasis to the uterus and/or ovaries
  • T2b : Fallopian tube/ovarian tumor with extension to other pelvic structures
  • T2c with malignant cells in ascites or peritoneal washings
  • T3 and/or N1 with peritoneal implants outside the pelvis and/or regional lymph node metastasis
  • T3a : Fallopian tube/ovarian tumor with microscopic peritoneal metastasis beyond pelvis
  • T3b : Fallopian tube/ovarian tumor with macroscopic peritoneal metastasis beyond pelvis < 2 cm in greatest dimension
  • T3c : Fallopian tube/ovarian tumor with peritoneal metastasis beyond pelvis > 2 cm in greatest dimension and/or regional lymph node metastasis

Information for Patients


Uterine Cancer

Also called: Endometrial cancer

The uterus, or womb, is the place where a baby grows when a women is pregnant. There are different types of uterine cancer. The most common type starts in the endometrium, the lining of the uterus. This type is also called endometrial cancer.

The symptoms of uterine cancer include

  • Abnormal vaginal bleeding or discharge
  • Trouble urinating
  • Pelvic pain
  • Pain during intercourse

Uterine cancer usually happens after menopause. It is more common in women who have obesity. You also have a higher risk if you took estrogen-only hormone replacement therapy (menopausal hormone therapy) for many years.

Tests to find uterine cancer include a pelvic exam, imaging tests, and a biopsy. The most common treatment is a hysterectomy, which is surgery to remove the uterus. Sometimes the surgery also removes the ovaries and fallopian tubes. Other treatments include hormone therapy, radiation therapy, and chemotherapy. Some women get more than one type of treatment.

NIH: National Cancer Institute

  • Choriocarcinoma (Medical Encyclopedia)
  • Endometrial biopsy (Medical Encyclopedia)
  • Endometrial cancer (Medical Encyclopedia)
  • Uterine Cancer (Centers for Disease Control and Prevention)
  • What to Know about Brachytherapy (A Type of Internal Radiation Therapy) - NIH - Easy-to-Read (National Cancer Institute)
  • What to Know about External Beam Radiation Therapy - NIH - Easy-to-Read (National Cancer Institute)

[Read More]

ICD-10 Footnotes

General Equivalence Map Definitions
The ICD-10 and ICD-9 GEMs are used to facilitate linking between the diagnosis codes in ICD-9-CM and the new ICD-10-CM code set. The GEMs are the raw material from which providers, health information vendors and payers can derive specific applied mappings to meet their needs.

  • Approximate Flag - The approximate flag is on, indicating that the relationship between the code in the source system and the code in the target system is an approximate equivalent.
  • No Map Flag - The no map flag indicates that a code in the source system is not linked to any code in the target system.
  • Combination Flag - The combination flag indicates that more than one code in the target system is required to satisfy the full equivalent meaning of a code in the source system.

Present on Admission
The Present on Admission (POA) indicator is used for diagnosis codes included in claims involving inpatient admissions to general acute care hospitals. POA indicators must be reported to CMS on each claim to facilitate the grouping of diagnoses codes into the proper Diagnostic Related Groups (DRG). CMS publishes a listing of specific diagnosis codes that are exempt from the POA reporting requirement.

Previous Code
C57.0
Next Code
C57.01